Open Access
Med Sci (Paris)
Volume 37, Number 11, Novembre 2021
Page(s) 1035 - 1041
Section Repères
Published online 01 December 2021
  1. Ioannidis JP. How to make more published research true. PLoS Med 2014 ; 11 : e1001747. [CrossRef] [PubMed] [Google Scholar]
  2. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets?. Nat Rev Drug Discov 2011 ; 10 : 712. [CrossRef] [PubMed] [Google Scholar]
  3. De Lacey G, Record C, Wade J. How accurate are quotations and references in medical journals?. Br Med J 1985 ; 291 : 884–886. [CrossRef] [PubMed] [Google Scholar]
  4. Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ 2009 ; 339 : b2680. [CrossRef] [PubMed] [Google Scholar]
  5. Duyx B, Urlings MJE, Swaen GMH, et al. Scientific citations favor positive results: a systematic review and meta-analysis. J Clin Epidemiol 2017 ; 88 : 92–101. [CrossRef] [PubMed] [Google Scholar]
  6. Jergas H, Baethge C. Quotation accuracy in medical journal articles-a systematic review and meta-analysis. PeerJ 2015 ; 3 : e1364. [CrossRef] [PubMed] [Google Scholar]
  7. Mogull SA. Accuracy of cited facts in medical research articles: a review of study methodology and recalculation of quotation error rate. PLoS One 2017 ; 12 : e0184727. [Google Scholar]
  8. Pavlovic V, Weissgerber T, Stanisavljevic D, et al. How accurate are citations of frequently cited papers in biomedical literature? Clin Sci (Lond) 2021; 135 : 671–81. [CrossRef] [PubMed] [Google Scholar]
  9. Tatsioni A, Bonitsis NG, Ioannidis JP. Persistence of contradicted claims in the literature. JAMA 2007 ; 298 : 2517–2526. [CrossRef] [PubMed] [Google Scholar]
  10. Urlings MJE, Duyx B, Swaen GMH, et al. Citation bias and other determinants of citation in biomedical research: findings from six citation networks. J Clin Epidemiol 2021; 132 : 71–8. [CrossRef] [PubMed] [Google Scholar]
  11. Frank RA, Sharifabadi AD, Salameh JP, et al. Citation bias in imaging research: are studies with higher diagnostic accuracy estimates cited more often?. Eur Radiol 2019 ; 29 : 1657–1664. [CrossRef] [PubMed] [Google Scholar]
  12. Treanor L, Frank RA, Salameh JP, et al. Selective citation practices in imaging research: are diagnostic accuracy studies with positive titles and conclusions cited more often?. Am J Roentgenol 2019 ; 213 : 397–403. [CrossRef] [PubMed] [Google Scholar]
  13. Armstrong MF, Conduff JH, 3rd, Fenton JE, Coelho DH. Reference errors in otolaryngology-head and neck surgery literature. Otolaryngol Head Neck Surg 2018 ; 159 : 249–253. [CrossRef] [PubMed] [Google Scholar]
  14. Baethge C. Importance, errors, and patterns of quotations to psychiatric original articles. Pharmacopsychiatry 2020; 53 : 247–55. [CrossRef] [PubMed] [Google Scholar]
  15. Smith N, Cumberledge A. Quotation errors in general science journals: quotation errors in science journals. Proc Roy Soc A 2020; 476 : 20200538. [CrossRef] [Google Scholar]
  16. Hui A, Rains LS, Todd A, et al. The accuracy and accessibility of cited evidence: a study examining mental health policy documents. Soc Psychiatry Psychiatr Epidemiol 2020; 55 : 111–21. [CrossRef] [PubMed] [Google Scholar]
  17. Jalal H, Buchanich JM, Roberts MS, et al. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 2018; 361 : eaau1184. [CrossRef] [PubMed] [Google Scholar]
  18. Healton C, Pack R, Galea S. The opioid crisis, corporate responsibility, and lessons from the tobacco master settlement agreement. JAMA 2019 ; 322 : 2071–2072. [CrossRef] [PubMed] [Google Scholar]
  19. Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959–2017. JAMA 2019 ; 322 : 1996–2016. [CrossRef] [PubMed] [Google Scholar]
  20. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009 ; 99 : 221–227. [CrossRef] [PubMed] [Google Scholar]
  21. Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA 2018 ; 320 : 2448–2460. [CrossRef] [PubMed] [Google Scholar]
  22. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med 2015 ; 162 : 276–286. [CrossRef] [PubMed] [Google Scholar]
  23. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980 ; 302 : 123. [Google Scholar]
  24. Leung PTM, Macdonald EM, Stanbrook MB, et al. A 1980 letter on the risk of opioid addiction. N Engl J Med 2017 ; 376 : 2194–2195. [CrossRef] [PubMed] [Google Scholar]
  25. Becker WC, Fiellin DA. Limited evidence, faulty reasoning, and potential for a global opioid crisis. BMJ 2017 ; 358 : j3115. [CrossRef] [PubMed] [Google Scholar]
  26. Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc 2018 ; 93 : 344–350. [CrossRef] [PubMed] [Google Scholar]
  27. Keng A, Coley RM. Evaluating the accuracy of citations in drug promotional brochures. Ann Pharmacother 1994 ; 28 : 1231–1235. [CrossRef] [PubMed] [Google Scholar]
  28. Gonzalez-Santiago M, Bucher HC, Nordmann AJ. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BMC Med Inform Decis Mak 2008 ; 8 : 61. [CrossRef] [PubMed] [Google Scholar]
  29. Spielmans GI, Thielges SA, Dent AL, Greenberg RP. The accuracy of psychiatric medication advertisements in medical journals. J Nerv Ment Dis 2008 ; 196 : 267–273. [CrossRef] [PubMed] [Google Scholar]
  30. Bero LA, Glantz SA, Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA 1994 ; 272 : 133–136. [CrossRef] [PubMed] [Google Scholar]
  31. Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med Infect Dis 2020 : 101663. [CrossRef] [PubMed] [Google Scholar]
  32. Million M, Lagier JC, Gautret P, et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille France. Travel Med Infect Dis 2020 : 101738. [CrossRef] [PubMed] [Google Scholar]
  33. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 : 1054–62. [CrossRef] [PubMed] [Google Scholar]
  34. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20 : 656–7. [CrossRef] [PubMed] [Google Scholar]
  35. Fiolet T, Guihur A, Rebeaud ME, et al. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol Infect 2020 ; 27: 19–27. [Google Scholar]
  36. Juul S, Nielsen EE, Feinberg J, et al. Interventions for treatment of COVID-19: a living systematic review with meta-analyses and trial sequential analyses (The Living Project). PLoS Med 2020; 17 : e1003293. [CrossRef] [PubMed] [Google Scholar]
  37. Siemieniuk RA, Bartoszko JJ, Ge L, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ 2020; 370 : m2980. [CrossRef] [PubMed] [Google Scholar]
  38. Peiffer-Smadja N, Rebeaud ME, Guihur A, et al. Hydroxychloroquine and COVID-19: a tale of populism and obscurantism. Lancet Infect Dis 2021; 21 : e121. [CrossRef] [PubMed] [Google Scholar]
  39. Ektorp E. Death threats after a trial on chloroquine for COVID-19. Lancet Infect Dis 2020; 20 : 661. [CrossRef] [PubMed] [Google Scholar]
  40. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56 : 105949. [CrossRef] [PubMed] [Google Scholar]
  41. Kim AHJ, Sparks JA, Liew JW, et al. A Rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for Covid-19. Ann Intern Med 2020; 172 : 819–21. [CrossRef] [PubMed] [Google Scholar]
  42. Alperovitch A, Lazar P. L’éthique des essais thérapeutiques. Med Sci (Paris) 2020; 36 : 303–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  43. Amiel P, Chneiweiss H, Dosquet C. Covid-19 : protocoles de soins ou protocoles de recherche ? Med Sci (Paris) 2020; 36 : 521–3. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.